Abstract
Background
To evaluate the efficacy of a silver nanoparticle (AgNP)-coated self-expandable metallic stent (SEMS) for suppressing tissue hyperplasia in a rat esophageal model.
Methods
Twenty-four male Sprague-Dawley rats were randomly assigned to four groups. Animals in group A underwent uncoated SEMS placement, whereas animals in groups B, C, and D underwent 6, 12, and 24 mg/mL AgNP-coated SEMS placement, respectively. All animals were euthanized 4 weeks after SEMS placement, and a gross examination and histological analyses were performed.
Results
All rats achieved technical success and survived until the end of the study. The gross examination showed moderate to severe tissue hyperplasia in 5 rats in group A and 2 rats in group B. In contrast, no animals in groups C and D had moderate or severe tissue hyperplasia. The gross examination revealed no complications. The percentage of granulation tissue area, number of epithelial layers, thickness of submucosal fibrosis, percentage of connective tissue area, inflammatory cell infiltration grade, degree of collagen deposition, and degrees of Ki67, TUNEL, and α-SMA-positive deposition were significantly lower in groups C and D than in group A (all p < 0.05). However, only the percentage of granulation tissue area, number of epithelial layers, thickness of submucosal fibrosis, and percentage of connective tissue area were significantly lower in group B than in group A (all p < 0.05). No histological parameters were significantly different between group D and group C (all p > 0.05).
Conclusion
AgNP-coated SEMSs suppressed tissue hyperplasia in a rat esophageal model.
Similar content being viewed by others
References
Sharma P, Kozarek R (2010) Role of esophageal stents in benign and malignant diseases. The American Journal of Gastroenterology 105:258–273
Ross WA, Alkassab F, Lynch PM, Ayers GD, Ajani J, Lee JH, Bismar M (2007) Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 65:70–76
Zhu HD, Guo JH, Mao AW, Lv WF, Ji JS, Wang WH, Lv B, Yang RM, Wu W, Ni CF, Min J, Zhu GY, Chen L, Zhu ML, Dai ZY, Liu PF, Gu JP, Ren WX, Shi RH, Xu GF, He SC, Deng G, Teng GJ (2014) Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial. Lancet Oncol 15:612–619
Song HY, Do YS, Han YM, Sung KB, Choi EK, Sohn KH, Kim HR, Kim SH, Min YI (1994) Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. Radiology 193:689–695
Song HY, Park SI, Do YS, Yoon HK, Sung KB, Sohn KH, Min YI (1997) Expandable metallic stent placement in patients with benign esophageal strictures: results of long-term follow-up. Radiology 203:131–136
Kim JH, Song HY, Choi EK, Kim KR, Shin JH, Lim JO (2009) Temporary metallic stent placement in the treatment of refractory benign esophageal strictures: results and factors associated with outcome in 55 patients. Eur Radiol 19:384–390
Holm AN, de la Mora Levy JG, Gostout CJ, Topazian MD, Baron TH (2008) Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc 67:20–25
Jun EJ, Park JH, Tsauo J, Yang SG, Kim DK, Kim KY, Kim MT, Yoon SH, Lim YJ, Song HY (2017) EW-7197, an activin-like kinase 5 inhibitor, suppresses granulation tissue after stent placement in rat esophagus. Gastrointest Endosc 86:219–228
Canena JM, Liberato MJ, Rio-Tinto RA, Pinto-Marques PM, Romão CM, Coutinho AV, Neves BA, Santos-Silva MF (2012) A comparison of the temporary placement of 3 different self-expanding stents for the treatment of refractory benign esophageal strictures: a prospective multicentre study. BMC gastroenterology 12:70
Wong KK, Cheung SO, Huang L, Niu J, Tao C, Ho CM, Che CM, Tam PK (2009) Further evidence of the anti-inflammatory effects of silver nanoparticles. ChemMedChem 4:1129–1135
Gurunathan S, Lee KJ, Kalishwaralal K, Sheikpranbabu S, Vaidyanathan R, Eom SH (2009) Antiangiogenic properties of silver nanoparticles. Biomaterials 30:6341–6350
Wei L, Lu J, Xu H, Patel A, Chen ZS, Chen G (2015) Silver nanoparticles: synthesis, properties, and therapeutic applications. Drug Discovery Today 20:595–601
Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briedé JJ, van Loveren H, de Jong WH (2011) The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 32:9810–9817
Baatar D, Jones MK, Tsugawa K, Pai R, Moon WS, Koh GY, Kim I, Kitano S, Tarnawski AS (2002) Esophageal ulceration triggers expression of hypoxia-inducible factor-1 alpha and activates vascular endothelial growth factor gene: implications for angiogenesis and ulcer healing. The American journal of pathology 161:1449–1457
Park JH, Park W, Cho S, Kim KY, Tsauo J, Yoon SH, Son WC, Kim DH, Song HY (2018) Nanofunctionalized Stent-Mediated Local Heat Treatment for the Suppression of Stent-Induced Tissue Hyperplasia. ACS Appl Mater Interfaces 10:29357–29366
Park W, Kim KY, Kang JM, Ryu DS, Kim DH, Song HY, Kim SH, Lee SO, Park JH (2020) Metallic Stent Mesh Coated with Silver Nanoparticles Suppresses Stent-Induced Tissue Hyperplasia and Biliary Sludge in the Rabbit Extrahepatic Bile Duct. Pharmaceutics 12:563
Xu J, Xu N, Zhou T, Xiao X, Gao B, Fu J, Zhang T (2017) Polydopamine coatings embedded with silver nanoparticles on nanostructured titania for long-lasting antibacterial effect. Surf Coat Technol 320:608–613
Kim EY, Shin JH, Jung YY, Shin DH, Song HY (2010) A rat esophageal model to investigate stent-induced tissue hyperplasia. Journal of vascular and interventional radiology : JVIR 21:1287–1291
Greenfield EA (2017) Sampling and Preparation of Mouse and Rat Serum. Cold Spring Harbor protocols. https://doi.org/10.1101/pdb.prot100271
Kim EY, Song HY, Kim JH, Fan Y, Park S, Kim DK, Lee EW, Na HK (2013) IN-1233-eluting covered metallic stent to prevent hyperplasia: experimental study in a rabbit esophageal model. Radiology 267:396–404
Samuel U, Guggenbichler JP (2004) Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 23(Suppl 1):S75-78
Lee TH, Jung MK, Kim TK, Pack CG, Park YK, Kim SO, Park DH (2019) Safety and efficacy of a metal stent covered with a silicone membrane containing integrated silver particles in preventing biofilm and sludge formation in endoscopic drainage of malignant biliary obstruction: a phase 2 pilot study. Gastrointest Endosc 90:663-672.e662
Tanaka T, Takahashi M, Nitta N, Furukawa A, Andoh A, Saito Y, Fujiyama Y, Murata K (2006) Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion 74:199–205
Kim EY, Shin JH, Song HY, Kim JH, Lee EW, Kim WJ, Shin DH, Lee H (2014) Suppression of stent-induced tissue hyperplasia in rats by using small interfering RNA to target matrix metalloproteinase-9. Endoscopy 46:507–512
Zhu YQ, Yang K, Edmonds L, Wei LM, Zheng R, Cheng RY, Cui WG, Cheng YS (2017) Silicone-covered biodegradable magnesium-stent insertion in the esophagus: a comparison with plastic stents. Therapeutic advances in gastroenterology 10:11–19
Griffiths EA, Gregory CJ, Pursnani KG, Ward JB, Stockwell RC (2012) The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease. Surg Endosc 26:2367–2375
Saito Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, Nitta N, Murata K, Fujiyama Y (2008) Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci 53:330–333
Repici A, Vleggaar FP, Hassan C, van Boeckel PG, Romeo F, Pagano N, Malesci A, Siersema PD (2010) Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest Endosc 72:927–934
Walter D, van den Berg MW, Hirdes MM, Vleggaar FP, Repici A, Deprez PH, Viedma BL, Lovat LB, Weusten BL, Bisschops R, Haidry R, Ferrara E, Sanborn KJ, O’Leary EE, van Hooft JE, Siersema PD (2018) Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial. Endoscopy 50:1146–1155
Funding
This work was supported by the National Natural Science Fund of China (Grant Nos. 82001937 & 81871468) and the Fundamental Research Funds for the Central Universities (Grant No. 3332018076).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
He Zhao, Yan Fu, Jiaywei Tsauo, Xiaowu Zhang, Yanqing Zhao, Tao Gong, Jingui Li, and Xiao Li have no conflicts of interest or financial ties to disclose.
Ethical approval
All applicable institutional and/or national guidelines for the care and use of animals were followed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhao, H., Fu, Y., Tsauo, J. et al. Silver nanoparticle-coated self-expandable metallic stent suppresses tissue hyperplasia in a rat esophageal model. Surg Endosc 36, 66–74 (2022). https://doi.org/10.1007/s00464-020-08238-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-08238-4